您的位置: 首页 > 农业专利 > 详情页

Adenozin A2a receptor anatgonisták
专利权人:
MERCK SHARP & DOHME CORP.
发明人:
NEUSTADT BERNARD R.,LINDO NEIL A.,GREENLEE WILLIAM J.,TULSHIAN DEEN,SILVERMAN LISA S.,XIA YAN,BOYLE CRAIG D.,CHACKALAMANNIL SAMUEL
申请号:
HU0600239
公开号:
HU230420B1
申请日:
2001.05.24
申请国别(地区):
HU
年份:
2016
代理人:
摘要:
Compounds having the structural formula I or a pharmaceutically acceptable salt thereof, wherein R is optionally substituted phenyl, cycloalkenyl, or heteroaryl; X is alkylene or -C(O)CH<;SUB>;2<;/SUB>;-; Y is -N(R<;SUP>;2<;/SUP>;)CH<;SUB>;2<;/SUB>;CH<;SUB>;2<;/SUB>;N(R<;SUP>;3<;/SUP>;)-, -OCH<;SUB>;2<;/SUB>;CH<;SUB>;2<;/SUB>;N(R<;SUP>;2<;/SUP>;)-, -O-, -S-, -CH<;SUB>;2<;/SUB>;S-, -(CH<;SUB>;2<;/SUB>;)<;SUB>;2<;/SUB>;-NH-, or optionally substituted m and n are 2-3, and Q is nitrogen or optionally substituted carbon; and Z is optionally substituted phenyl, phenylalkyl or heteroaryl, diphenylmethyl, R<;SUP>;6<;/SUP>;-C(O)-, R<;SUP>;6<;/SUP>;-SO<;SUB>;2<;/SUB>;-, R<;SUP>;6<;/SUP>;-OC(O)-, R<;SUP>;7<;/SUP>;-N(R<;SUP>;8<;/SUP>;)-C(O)-, R<;SUP>;7<;/SUP>;-N(R<;SUP>;8<;/SUP>;)-C(S)-, phenyl-CH(OH)-, or phenyl-C(-NOR<;SUP>;2<;/SUP>;)-; or when Q is CH, phenylamino or pyridylamino; or Z and Y together are substituted piperidinyl or substituted phenyl; and R<;SUP>;2<;/SUP>;, R<;SUP>;3<;/SUP>;, R<;SUP>;6<;/SUP>;, R<;SUP>;7<;/SUP>;, and R<;SUP>;8 <;/SUP>;are as defined in the specification are disclosed, their use in the treatment of Parkinson's disease, alone or in combination with other agents for treating Parkinson's disease, and pharmaceutical compositions comprising them; also disclosed are a processes for preparing intermediates useful for preparing compounds of formula I.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充